 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Diabetes Drugs and Cardiovascular Safety |
| Ji Cheol Bae |
|
Endocrinol Metab. 2016;31(2):239-244. Published online June 10, 2016 DOI: https://doi.org/10.3803/EnM.2016.31.2.239 |
|
The Genesis of Cardiovascular Safety Regulatory Landscapes for New Antidiabetic Drugs for Type 2 Diabetes Cardiovascular Safety in Drug Development and Therapeutic Use. 2016;239-250  Diabetes Drugs and Cardiovascular Safety Endocrinology and Metabolism. 2016;31(2):239 Recent cardiovascular safety trials with antidiabetic drugs: time to change the guidelines! Practical Diabetes. 2015;32(9):319-320 Drugs and diabetes: understanding the new breed of cardiovascular safety trials The Lancet Diabetes & Endocrinology. 2013;1(3):175-177 Editorial commentary: New drugs for diabetes: Finally safety and cardiovascular efficacy Trends in Cardiovascular Medicine. 2017;27(5):376-377 Cardiovascular safety trials of incretin-based drugs: What do they mean? Journal of Diabetes Investigation. 2016;8(3):272-276 Encainide?An updated safety profile Cardiovascular Drugs and Therapy. 1990;4(S3):585-594 A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data Journal of Diabetes and its Complications. 2017;31(12):1719-1727 Cardiovascular safety and DPP-4 inhibitors Practical Diabetes. 2013;30(2):78-81 Cardiovascular Safety of New Drugs for Diabetes: Getting the Balance Right? Pharmaceutical Medicine. 2014;28(3):109-117 |
